NeueHealth PE Ratio 2019-2025 | NEUE

Current and historical p/e ratio for NeueHealth (NEUE) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NeueHealth PE ratio as of June 25, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

NeueHealth PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-25 6.84 0.00
2025-03-31 6.76 $-22.00 0.00
2024-12-31 7.42 $-22.63 0.00
2024-09-30 5.22 $-51.16 0.00
2024-06-30 5.44 $-123.68 0.00
2024-03-31 6.50 $-130.73 0.00
2023-12-31 7.63 $-151.20 0.00
2023-09-30 5.97 $-208.73 0.00
2023-06-30 12.22 $-167.70 0.00
2023-03-31 17.60 $-188.00 0.00
2022-12-31 52.00 $-189.60 0.00
2022-09-30 84.00 $-204.80 0.00
2022-06-30 145.60 $-203.20 0.00
2022-03-31 154.40 $-189.60 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.061B $0.937B
NeueHealth is a healthcare company which provides health insurance policies principally in the United States. Its operating segments include Bright HealthCare and Consumer Care. NeueHealth, formerly known as Bright Health Group Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.323B 26.51
CVS Health (CVS) United States $85.490B 10.63
Elevance Health (ELV) United States $85.046B 10.97
Cencora (COR) United States $57.007B 19.83
Natera (NTRA) United States $23.468B 0.00
DiDi Global (DIDIY) China $23.015B 24.45
Labcorp Holdings (LH) United States $21.974B 17.82
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.262B 0.00
Solventum (SOLV) United States $12.973B 13.73
CochLear (CHEOY) Australia $12.633B 0.00
ICON (ICLR) Ireland $11.996B 11.15
Revvity (RVTY) United States $11.361B 19.55
Viatris (VTRS) United States $10.504B 3.61
Avantor (AVTR) United States $9.172B 13.33
Medpace Holdings (MEDP) United States $9.062B 24.07
HealthEquity (HQY) United States $9.009B 39.46
Sonic Healthcare (SKHHY) Australia $8.263B 0.00
Charles River Laboratories (CRL) United States $7.289B 14.28
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.259B 25.08
BrightSpring Health Services (BTSG) United States $4.024B 36.92
Sotera Health (SHC) United States $3.191B 18.13
Alignment Healthcare (ALHC) United States $2.786B 0.00
Concentras Parent (CON) United States $2.716B 15.70
Surgery Partners (SGRY) United States $2.705B 35.18
GeneDx Holdings (WGS) United States $2.594B 99.89
Organon (OGN) United States $2.587B 2.75
PACS (PACS) United States $1.928B 0.00
Ardent Health (ARDT) United States $1.887B 8.04
Progyny (PGNY) United States $1.822B 40.11
GoodRx Holdings (GDRX) United States $1.811B 36.21
Premier (PINC) United States $1.791B 13.59
Teladoc Health (TDOC) United States $1.403B 0.00
Pediatrix Medical (MD) United States $1.158B 8.81
CareDx (CDNA) United States $1.051B 16.42
Establishment Labs Holdings (ESTA) $1.034B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.915B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.831B 7.78
Nutex Health (NUTX) United States $0.641B 9.70
LifeMD (LFMD) United States $0.639B 0.00
Embecta (EMBC) United States $0.597B 4.02
InnovAge Holding (INNV) United States $0.545B 0.00
Enhabit (EHAB) United States $0.482B 39.62
Sonida Senior Living (SNDA) United States $0.463B 0.00
Auna S.A (AUNA) Luxembourg $0.463B 10.42
SBC Medicals (SBC) United States $0.442B 0.00
Omada Health (OMDA) $0.404B 0.00
Performant Healthcare (PHLT) United States $0.298B 0.00
Beauty Health (SKIN) United States $0.242B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.237B 0.00
Oncology Institute (TOI) United States $0.210B 0.00
DocGo (DCGO) United States $0.176B 28.83
So-Young (SY) China $0.174B 0.00
Pheton Holdings (PTHL) China $0.123B 0.00
OncoCyte (IMDX) United States $0.099B 0.00
KindlyMD (NAKA) United States $0.092B 0.00
Sera Prognostics (SERA) United States $0.076B 0.00
Ascend Wellness Holdings (AAWH) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.046B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00